 | • レポートコード：QY2203B04667 • 出版社/出版日：QYResearch / 2022年3月18日 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のハーセプチン（トラスツズマブ）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にハーセプチン（トラスツズマブ）の世界市場のxxx％を占める「乳がん」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のハーセプチン（トラスツズマブ）の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのハーセプチン（トラスツズマブ）市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのハーセプチン（トラスツズマブ）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ハーセプチン（トラスツズマブ）のグローバル主要メーカーには、Roche Diagnostics、Genentech、Novartis AG、Pfizer、Abnova Corporation、InvivoGen、Celltrion、Biocon Limited、Bio-Techne、Amgen、Samsung Bioepis、Merck、Mylan、Teva Pharmaceutical、Mundipharma、Mabion、AryoGen Biopharma、Genor Biopharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ハーセプチン（トラスツズマブ）市場は、種類と用途によって区分されます。世界のハーセプチン（トラスツズマブ）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 乳がん、胃がん、その他 【用途別セグメント】 病院、医療センター 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ハーセプチン（トラスツズマブ）製品概要 - 種類別市場（乳がん、胃がん、その他） - 用途別市場（病院、医療センター） - 調査の目的 ・エグゼクティブサマリー - 世界のハーセプチン（トラスツズマブ）販売量予測2017-2028 - 世界のハーセプチン（トラスツズマブ）売上予測2017-2028 - ハーセプチン（トラスツズマブ）の地域別販売量 - ハーセプチン（トラスツズマブ）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ハーセプチン（トラスツズマブ）販売量 - 主要メーカー別ハーセプチン（トラスツズマブ）売上 - 主要メーカー別ハーセプチン（トラスツズマブ）価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（乳がん、胃がん、その他） - ハーセプチン（トラスツズマブ）の種類別販売量 - ハーセプチン（トラスツズマブ）の種類別売上 - ハーセプチン（トラスツズマブ）の種類別価格 ・用途別市場規模（病院、医療センター） - ハーセプチン（トラスツズマブ）の用途別販売量 - ハーセプチン（トラスツズマブ）の用途別売上 - ハーセプチン（トラスツズマブ）の用途別価格 ・北米市場 - 北米のハーセプチン（トラスツズマブ）市場規模（種類別、用途別） - 主要国別のハーセプチン（トラスツズマブ）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのハーセプチン（トラスツズマブ）市場規模（種類別、用途別） - 主要国別のハーセプチン（トラスツズマブ）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のハーセプチン（トラスツズマブ）市場規模（種類別、用途別） - 主要国別のハーセプチン（トラスツズマブ）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のハーセプチン（トラスツズマブ）市場規模（種類別、用途別） - 主要国別のハーセプチン（トラスツズマブ）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのハーセプチン（トラスツズマブ）市場規模（種類別、用途別） - 主要国別のハーセプチン（トラスツズマブ）市場規模（トルコ、サウジアラビア） ・企業情報 Roche Diagnostics、Genentech、Novartis AG、Pfizer、Abnova Corporation、InvivoGen、Celltrion、Biocon Limited、Bio-Techne、Amgen、Samsung Bioepis、Merck、Mylan、Teva Pharmaceutical、Mundipharma、Mabion、AryoGen Biopharma、Genor Biopharma ・産業チェーン及び販売チャネル分析 - ハーセプチン（トラスツズマブ）の産業チェーン分析 - ハーセプチン（トラスツズマブ）の原材料 - ハーセプチン（トラスツズマブ）の生産プロセス - ハーセプチン（トラスツズマブ）の販売及びマーケティング - ハーセプチン（トラスツズマブ）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ハーセプチン（トラスツズマブ）の産業動向 - ハーセプチン（トラスツズマブ）のマーケットドライバー - ハーセプチン（トラスツズマブ）の課題 - ハーセプチン（トラスツズマブ）の阻害要因 ・主な調査結果 |
Herceptin (Trastuzumab) is a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body’s own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer that has received one or more chemotherapy regimens; It can be combined with paclitaxel to treat metastatic breast cancer without chemotherapy.
Market Analysis and Insights: Global Herceptin (Trastuzumab) Market
Due to the COVID-19 pandemic, the global Herceptin (Trastuzumab) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Breast Cancer accounting for % of the Herceptin (Trastuzumab) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Herceptin (Trastuzumab) market size is valued at US$ million in 2021, while the US and Europe Herceptin (Trastuzumab) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Herceptin (Trastuzumab) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Herceptin (Trastuzumab) include Roche Diagnostics, Genentech, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Herceptin (Trastuzumab) Scope and Segment
Herceptin (Trastuzumab) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Herceptin (Trastuzumab) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Breast Cancer
Stomach Cancer
Others
Segment by Application
Hospital
Medical Center
By Company
Roche Diagnostics
Genentech
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Amgen
Samsung Bioepis
Merck
Mylan
Teva Pharmaceutical
Mundipharma
Mabion
AryoGen Biopharma
Genor Biopharma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Herceptin (Trastuzumab) Product Introduction
1.2 Market by Type
1.2.1 Global Herceptin (Trastuzumab) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Breast Cancer
1.2.3 Stomach Cancer
1.2.4 Others
1.3 Market by Application
1.3.1 Global Herceptin (Trastuzumab) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Medical Center
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Herceptin (Trastuzumab) Sales Estimates and Forecasts 2017-2028
2.2 Global Herceptin (Trastuzumab) Revenue Estimates and Forecasts 2017-2028
2.3 Global Herceptin (Trastuzumab) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Herceptin (Trastuzumab) Sales by Region
2.4.1 Global Herceptin (Trastuzumab) Sales by Region (2017-2022)
2.4.2 Global Sales Herceptin (Trastuzumab) by Region (2023-2028)
2.5 Global Herceptin (Trastuzumab) Revenue by Region
2.5.1 Global Herceptin (Trastuzumab) Revenue by Region (2017-2022)
2.5.2 Global Herceptin (Trastuzumab) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Herceptin (Trastuzumab) Sales by Manufacturers
3.1.1 Global Top Herceptin (Trastuzumab) Manufacturers by Sales (2017-2022)
3.1.2 Global Herceptin (Trastuzumab) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Herceptin (Trastuzumab) in 2021
3.2 Global Herceptin (Trastuzumab) Revenue by Manufacturers
3.2.1 Global Herceptin (Trastuzumab) Revenue by Manufacturers (2017-2022)
3.2.2 Global Herceptin (Trastuzumab) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Herceptin (Trastuzumab) Revenue in 2021
3.3 Global Herceptin (Trastuzumab) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Herceptin (Trastuzumab) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Herceptin (Trastuzumab) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Herceptin (Trastuzumab) Sales by Type
4.1.1 Global Herceptin (Trastuzumab) Historical Sales by Type (2017-2022)
4.1.2 Global Herceptin (Trastuzumab) Forecasted Sales by Type (2023-2028)
4.1.3 Global Herceptin (Trastuzumab) Sales Market Share by Type (2017-2028)
4.2 Global Herceptin (Trastuzumab) Revenue by Type
4.2.1 Global Herceptin (Trastuzumab) Historical Revenue by Type (2017-2022)
4.2.2 Global Herceptin (Trastuzumab) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Herceptin (Trastuzumab) Revenue Market Share by Type (2017-2028)
4.3 Global Herceptin (Trastuzumab) Price by Type
4.3.1 Global Herceptin (Trastuzumab) Price by Type (2017-2022)
4.3.2 Global Herceptin (Trastuzumab) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Herceptin (Trastuzumab) Sales by Application
5.1.1 Global Herceptin (Trastuzumab) Historical Sales by Application (2017-2022)
5.1.2 Global Herceptin (Trastuzumab) Forecasted Sales by Application (2023-2028)
5.1.3 Global Herceptin (Trastuzumab) Sales Market Share by Application (2017-2028)
5.2 Global Herceptin (Trastuzumab) Revenue by Application
5.2.1 Global Herceptin (Trastuzumab) Historical Revenue by Application (2017-2022)
5.2.2 Global Herceptin (Trastuzumab) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Herceptin (Trastuzumab) Revenue Market Share by Application (2017-2028)
5.3 Global Herceptin (Trastuzumab) Price by Application
5.3.1 Global Herceptin (Trastuzumab) Price by Application (2017-2022)
5.3.2 Global Herceptin (Trastuzumab) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Herceptin (Trastuzumab) Market Size by Type
6.1.1 North America Herceptin (Trastuzumab) Sales by Type (2017-2028)
6.1.2 North America Herceptin (Trastuzumab) Revenue by Type (2017-2028)
6.2 North America Herceptin (Trastuzumab) Market Size by Application
6.2.1 North America Herceptin (Trastuzumab) Sales by Application (2017-2028)
6.2.2 North America Herceptin (Trastuzumab) Revenue by Application (2017-2028)
6.3 North America Herceptin (Trastuzumab) Market Size by Country
6.3.1 North America Herceptin (Trastuzumab) Sales by Country (2017-2028)
6.3.2 North America Herceptin (Trastuzumab) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Herceptin (Trastuzumab) Market Size by Type
7.1.1 Europe Herceptin (Trastuzumab) Sales by Type (2017-2028)
7.1.2 Europe Herceptin (Trastuzumab) Revenue by Type (2017-2028)
7.2 Europe Herceptin (Trastuzumab) Market Size by Application
7.2.1 Europe Herceptin (Trastuzumab) Sales by Application (2017-2028)
7.2.2 Europe Herceptin (Trastuzumab) Revenue by Application (2017-2028)
7.3 Europe Herceptin (Trastuzumab) Market Size by Country
7.3.1 Europe Herceptin (Trastuzumab) Sales by Country (2017-2028)
7.3.2 Europe Herceptin (Trastuzumab) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Herceptin (Trastuzumab) Market Size by Type
8.1.1 Asia Pacific Herceptin (Trastuzumab) Sales by Type (2017-2028)
8.1.2 Asia Pacific Herceptin (Trastuzumab) Revenue by Type (2017-2028)
8.2 Asia Pacific Herceptin (Trastuzumab) Market Size by Application
8.2.1 Asia Pacific Herceptin (Trastuzumab) Sales by Application (2017-2028)
8.2.2 Asia Pacific Herceptin (Trastuzumab) Revenue by Application (2017-2028)
8.3 Asia Pacific Herceptin (Trastuzumab) Market Size by Region
8.3.1 Asia Pacific Herceptin (Trastuzumab) Sales by Region (2017-2028)
8.3.2 Asia Pacific Herceptin (Trastuzumab) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Herceptin (Trastuzumab) Market Size by Type
9.1.1 Latin America Herceptin (Trastuzumab) Sales by Type (2017-2028)
9.1.2 Latin America Herceptin (Trastuzumab) Revenue by Type (2017-2028)
9.2 Latin America Herceptin (Trastuzumab) Market Size by Application
9.2.1 Latin America Herceptin (Trastuzumab) Sales by Application (2017-2028)
9.2.2 Latin America Herceptin (Trastuzumab) Revenue by Application (2017-2028)
9.3 Latin America Herceptin (Trastuzumab) Market Size by Country
9.3.1 Latin America Herceptin (Trastuzumab) Sales by Country (2017-2028)
9.3.2 Latin America Herceptin (Trastuzumab) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Herceptin (Trastuzumab) Market Size by Type
10.1.1 Middle East and Africa Herceptin (Trastuzumab) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Herceptin (Trastuzumab) Revenue by Type (2017-2028)
10.2 Middle East and Africa Herceptin (Trastuzumab) Market Size by Application
10.2.1 Middle East and Africa Herceptin (Trastuzumab) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Herceptin (Trastuzumab) Revenue by Application (2017-2028)
10.3 Middle East and Africa Herceptin (Trastuzumab) Market Size by Country
10.3.1 Middle East and Africa Herceptin (Trastuzumab) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Herceptin (Trastuzumab) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Corporation Information
11.1.2 Roche Diagnostics Overview
11.1.3 Roche Diagnostics Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Diagnostics Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Diagnostics Recent Developments
11.2 Genentech
11.2.1 Genentech Corporation Information
11.2.2 Genentech Overview
11.2.3 Genentech Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Genentech Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Genentech Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis AG Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis AG Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Abnova Corporation
11.5.1 Abnova Corporation Corporation Information
11.5.2 Abnova Corporation Overview
11.5.3 Abnova Corporation Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Abnova Corporation Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abnova Corporation Recent Developments
11.6 InvivoGen
11.6.1 InvivoGen Corporation Information
11.6.2 InvivoGen Overview
11.6.3 InvivoGen Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 InvivoGen Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 InvivoGen Recent Developments
11.7 Celltrion
11.7.1 Celltrion Corporation Information
11.7.2 Celltrion Overview
11.7.3 Celltrion Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Celltrion Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Celltrion Recent Developments
11.8 Biocon Limited
11.8.1 Biocon Limited Corporation Information
11.8.2 Biocon Limited Overview
11.8.3 Biocon Limited Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Biocon Limited Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biocon Limited Recent Developments
11.9 Bio-Techne
11.9.1 Bio-Techne Corporation Information
11.9.2 Bio-Techne Overview
11.9.3 Bio-Techne Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Bio-Techne Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bio-Techne Recent Developments
11.10 Amgen
11.10.1 Amgen Corporation Information
11.10.2 Amgen Overview
11.10.3 Amgen Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Amgen Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Amgen Recent Developments
11.11 Samsung Bioepis
11.11.1 Samsung Bioepis Corporation Information
11.11.2 Samsung Bioepis Overview
11.11.3 Samsung Bioepis Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Samsung Bioepis Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Samsung Bioepis Recent Developments
11.12 Merck
11.12.1 Merck Corporation Information
11.12.2 Merck Overview
11.12.3 Merck Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Merck Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Merck Recent Developments
11.13 Mylan
11.13.1 Mylan Corporation Information
11.13.2 Mylan Overview
11.13.3 Mylan Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Mylan Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Mylan Recent Developments
11.14 Teva Pharmaceutical
11.14.1 Teva Pharmaceutical Corporation Information
11.14.2 Teva Pharmaceutical Overview
11.14.3 Teva Pharmaceutical Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Teva Pharmaceutical Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Teva Pharmaceutical Recent Developments
11.15 Mundipharma
11.15.1 Mundipharma Corporation Information
11.15.2 Mundipharma Overview
11.15.3 Mundipharma Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Mundipharma Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Mundipharma Recent Developments
11.16 Mabion
11.16.1 Mabion Corporation Information
11.16.2 Mabion Overview
11.16.3 Mabion Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Mabion Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Mabion Recent Developments
11.17 AryoGen Biopharma
11.17.1 AryoGen Biopharma Corporation Information
11.17.2 AryoGen Biopharma Overview
11.17.3 AryoGen Biopharma Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 AryoGen Biopharma Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 AryoGen Biopharma Recent Developments
11.18 Genor Biopharma
11.18.1 Genor Biopharma Corporation Information
11.18.2 Genor Biopharma Overview
11.18.3 Genor Biopharma Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Genor Biopharma Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Genor Biopharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Herceptin (Trastuzumab) Industry Chain Analysis
12.2 Herceptin (Trastuzumab) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Herceptin (Trastuzumab) Production Mode & Process
12.4 Herceptin (Trastuzumab) Sales and Marketing
12.4.1 Herceptin (Trastuzumab) Sales Channels
12.4.2 Herceptin (Trastuzumab) Distributors
12.5 Herceptin (Trastuzumab) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Herceptin (Trastuzumab) Industry Trends
13.2 Herceptin (Trastuzumab) Market Drivers
13.3 Herceptin (Trastuzumab) Market Challenges
13.4 Herceptin (Trastuzumab) Market Restraints
14 Key Findings in The Global Herceptin (Trastuzumab) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Herceptin (Trastuzumab) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Breast Cancer
Table 3. Major Manufacturers of Stomach Cancer
Table 4. Major Manufacturers of Others
Table 5. Global Herceptin (Trastuzumab) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Herceptin (Trastuzumab) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Herceptin (Trastuzumab) Sales by Region (2017-2022) & (K Units)
Table 8. Global Herceptin (Trastuzumab) Sales Market Share by Region (2017-2022)
Table 9. Global Herceptin (Trastuzumab) Sales by Region (2023-2028) & (K Units)
Table 10. Global Herceptin (Trastuzumab) Sales Market Share by Region (2023-2028)
Table 11. Global Herceptin (Trastuzumab) Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2017-2022)
Table 13. Global Herceptin (Trastuzumab) Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2023-2028)
Table 15. Global Herceptin (Trastuzumab) Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Herceptin (Trastuzumab) Sales Share by Manufacturers (2017-2022)
Table 17. Global Herceptin (Trastuzumab) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Herceptin (Trastuzumab) Revenue Share by Manufacturers (2017-2022)
Table 19. Herceptin (Trastuzumab) Price by Manufacturers (2017-2022) &(K USD/Unit)
Table 20. Global Herceptin (Trastuzumab) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Herceptin (Trastuzumab) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herceptin (Trastuzumab) as of 2021)
Table 22. Herceptin (Trastuzumab) Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Herceptin (Trastuzumab) Product Offered
Table 24. Date of Manufacturers Enter into Herceptin (Trastuzumab) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Herceptin (Trastuzumab) Sales by Type (2017-2022) & (K Units)
Table 27. Global Herceptin (Trastuzumab) Sales by Type (2023-2028) & (K Units)
Table 28. Global Herceptin (Trastuzumab) Sales Share by Type (2017-2022)
Table 29. Global Herceptin (Trastuzumab) Sales Share by Type (2023-2028)
Table 30. Global Herceptin (Trastuzumab) Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Herceptin (Trastuzumab) Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Herceptin (Trastuzumab) Revenue Share by Type (2017-2022)
Table 33. Global Herceptin (Trastuzumab) Revenue Share by Type (2023-2028)
Table 34. Herceptin (Trastuzumab) Price by Type (2017-2022) & (K USD/Unit)
Table 35. Global Herceptin (Trastuzumab) Price Forecast by Type (2023-2028) & (K USD/Unit)
Table 36. Global Herceptin (Trastuzumab) Sales by Application (2017-2022) & (K Units)
Table 37. Global Herceptin (Trastuzumab) Sales by Application (2023-2028) & (K Units)
Table 38. Global Herceptin (Trastuzumab) Sales Share by Application (2017-2022)
Table 39. Global Herceptin (Trastuzumab) Sales Share by Application (2023-2028)
Table 40. Global Herceptin (Trastuzumab) Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Herceptin (Trastuzumab) Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Herceptin (Trastuzumab) Revenue Share by Application (2017-2022)
Table 43. Global Herceptin (Trastuzumab) Revenue Share by Application (2023-2028)
Table 44. Herceptin (Trastuzumab) Price by Application (2017-2022) & (K USD/Unit)
Table 45. Global Herceptin (Trastuzumab) Price Forecast by Application (2023-2028) & (K USD/Unit)
Table 46. North America Herceptin (Trastuzumab) Sales by Type (2017-2022) & (K Units)
Table 47. North America Herceptin (Trastuzumab) Sales by Type (2023-2028) & (K Units)
Table 48. North America Herceptin (Trastuzumab) Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Herceptin (Trastuzumab) Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Herceptin (Trastuzumab) Sales by Application (2017-2022) & (K Units)
Table 51. North America Herceptin (Trastuzumab) Sales by Application (2023-2028) & (K Units)
Table 52. North America Herceptin (Trastuzumab) Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Herceptin (Trastuzumab) Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Herceptin (Trastuzumab) Sales by Country (2017-2022) & (K Units)
Table 55. North America Herceptin (Trastuzumab) Sales by Country (2023-2028) & (K Units)
Table 56. North America Herceptin (Trastuzumab) Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Herceptin (Trastuzumab) Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Herceptin (Trastuzumab) Sales by Type (2017-2022) & (K Units)
Table 59. Europe Herceptin (Trastuzumab) Sales by Type (2023-2028) & (K Units)
Table 60. Europe Herceptin (Trastuzumab) Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Herceptin (Trastuzumab) Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Herceptin (Trastuzumab) Sales by Application (2017-2022) & (K Units)
Table 63. Europe Herceptin (Trastuzumab) Sales by Application (2023-2028) & (K Units)
Table 64. Europe Herceptin (Trastuzumab) Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Herceptin (Trastuzumab) Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Herceptin (Trastuzumab) Sales by Country (2017-2022) & (K Units)
Table 67. Europe Herceptin (Trastuzumab) Sales by Country (2023-2028) & (K Units)
Table 68. Europe Herceptin (Trastuzumab) Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Herceptin (Trastuzumab) Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Herceptin (Trastuzumab) Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Herceptin (Trastuzumab) Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Herceptin (Trastuzumab) Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Herceptin (Trastuzumab) Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Herceptin (Trastuzumab) Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Herceptin (Trastuzumab) Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Herceptin (Trastuzumab) Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Herceptin (Trastuzumab) Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Herceptin (Trastuzumab) Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Herceptin (Trastuzumab) Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Herceptin (Trastuzumab) Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Herceptin (Trastuzumab) Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Herceptin (Trastuzumab) Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Herceptin (Trastuzumab) Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Herceptin (Trastuzumab) Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Herceptin (Trastuzumab) Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Herceptin (Trastuzumab) Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Herceptin (Trastuzumab) Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Herceptin (Trastuzumab) Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Herceptin (Trastuzumab) Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Herceptin (Trastuzumab) Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Herceptin (Trastuzumab) Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Herceptin (Trastuzumab) Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Herceptin (Trastuzumab) Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Herceptin (Trastuzumab) Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Herceptin (Trastuzumab) Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Herceptin (Trastuzumab) Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Herceptin (Trastuzumab) Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Herceptin (Trastuzumab) Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Herceptin (Trastuzumab) Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Herceptin (Trastuzumab) Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Herceptin (Trastuzumab) Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Herceptin (Trastuzumab) Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Herceptin (Trastuzumab) Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Herceptin (Trastuzumab) Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Herceptin (Trastuzumab) Revenue by Country (2023-2028) & (US$ Million)
Table 106. Roche Diagnostics Corporation Information
Table 107. Roche Diagnostics Description and Major Businesses
Table 108. Roche Diagnostics Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 109. Roche Diagnostics Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Roche Diagnostics Recent Developments
Table 111. Genentech Corporation Information
Table 112. Genentech Description and Major Businesses
Table 113. Genentech Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 114. Genentech Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Genentech Recent Developments
Table 116. Novartis AG Corporation Information
Table 117. Novartis AG Description and Major Businesses
Table 118. Novartis AG Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 119. Novartis AG Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Novartis AG Recent Developments
Table 121. Pfizer Corporation Information
Table 122. Pfizer Description and Major Businesses
Table 123. Pfizer Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 124. Pfizer Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Pfizer Recent Developments
Table 126. Abnova Corporation Corporation Information
Table 127. Abnova Corporation Description and Major Businesses
Table 128. Abnova Corporation Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 129. Abnova Corporation Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Abnova Corporation Recent Developments
Table 131. InvivoGen Corporation Information
Table 132. InvivoGen Description and Major Businesses
Table 133. InvivoGen Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 134. InvivoGen Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. InvivoGen Recent Developments
Table 136. Celltrion Corporation Information
Table 137. Celltrion Description and Major Businesses
Table 138. Celltrion Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 139. Celltrion Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Celltrion Recent Developments
Table 141. Biocon Limited Corporation Information
Table 142. Biocon Limited Description and Major Businesses
Table 143. Biocon Limited Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 144. Biocon Limited Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Biocon Limited Recent Developments
Table 146. Bio-Techne Corporation Information
Table 147. Bio-Techne Description and Major Businesses
Table 148. Bio-Techne Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 149. Bio-Techne Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Bio-Techne Recent Developments
Table 151. Amgen Corporation Information
Table 152. Amgen Description and Major Businesses
Table 153. Amgen Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 154. Amgen Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Amgen Recent Developments
Table 156. Samsung Bioepis Corporation Information
Table 157. Samsung Bioepis Description and Major Businesses
Table 158. Samsung Bioepis Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 159. Samsung Bioepis Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Samsung Bioepis Recent Developments
Table 161. Merck Corporation Information
Table 162. Merck Description and Major Businesses
Table 163. Merck Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 164. Merck Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Merck Recent Developments
Table 166. Mylan Corporation Information
Table 167. Mylan Description and Major Businesses
Table 168. Mylan Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 169. Mylan Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Mylan Recent Developments
Table 171. Teva Pharmaceutical Corporation Information
Table 172. Teva Pharmaceutical Description and Major Businesses
Table 173. Teva Pharmaceutical Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 174. Teva Pharmaceutical Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Teva Pharmaceutical Recent Developments
Table 176. Mundipharma Corporation Information
Table 177. Mundipharma Description and Major Businesses
Table 178. Mundipharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 179. Mundipharma Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Mundipharma Recent Developments
Table 181. Mabion Corporation Information
Table 182. Mabion Description and Major Businesses
Table 183. Mabion Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 184. Mabion Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 185. Mabion Recent Developments
Table 186. AryoGen Biopharma Corporation Information
Table 187. AryoGen Biopharma Description and Major Businesses
Table 188. AryoGen Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 189. AryoGen Biopharma Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 190. AryoGen Biopharma Recent Developments
Table 191. Genor Biopharma Corporation Information
Table 192. Genor Biopharma Description and Major Businesses
Table 193. Genor Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 194. Genor Biopharma Herceptin (Trastuzumab) Product Model Numbers, Pictures, Descriptions and Specifications
Table 195. Genor Biopharma Recent Developments
Table 196. Key Raw Materials Lists
Table 197. Raw Materials Key Suppliers Lists
Table 198. Herceptin (Trastuzumab) Distributors List
Table 199. Herceptin (Trastuzumab) Customers List
Table 200. Herceptin (Trastuzumab) Market Trends
Table 201. Herceptin (Trastuzumab) Market Drivers
Table 202. Herceptin (Trastuzumab) Market Challenges
Table 203. Herceptin (Trastuzumab) Market Restraints
Table 204. Research Programs/Design for This Report
Table 205. Key Data Information from Secondary Sources
Table 206. Key Data Information from Primary Sources
List of Figures
Figure 1. Herceptin (Trastuzumab) Product Picture
Figure 3. Global Herceptin (Trastuzumab) Market Share by Type in 2021 & 2028
Figure 3. Breast Cancer Product Picture
Figure 4. Stomach Cancer Product Picture
Figure 5. Others Product Picture
Figure 6. Global Herceptin (Trastuzumab) Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Medical Center
Figure 9. Herceptin (Trastuzumab) Report Years Considered
Figure 10. Global Herceptin (Trastuzumab) Sales 2017-2028 (K Units)
Figure 11. Global Herceptin (Trastuzumab) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Herceptin (Trastuzumab) Revenue 2017-2028 (US$ Million)
Figure 13. Global Herceptin (Trastuzumab) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Herceptin (Trastuzumab) Sales Market Share by Region (2017-2022)
Figure 15. Global Herceptin (Trastuzumab) Sales Market Share by Region (2023-2028)
Figure 16. North America Herceptin (Trastuzumab) Sales YoY (2017-2028) & (K Units)
Figure 17. North America Herceptin (Trastuzumab) Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Herceptin (Trastuzumab) Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Herceptin (Trastuzumab) Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Herceptin (Trastuzumab) Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Herceptin (Trastuzumab) Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Herceptin (Trastuzumab) Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Herceptin (Trastuzumab) Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Herceptin (Trastuzumab) Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Herceptin (Trastuzumab) Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Herceptin (Trastuzumab) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Herceptin (Trastuzumab) in the World: Market Share by Herceptin (Trastuzumab) Revenue in 2021
Figure 28. Global Herceptin (Trastuzumab) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Herceptin (Trastuzumab) Sales Market Share by Type (2017-2028)
Figure 30. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2017-2028)
Figure 31. Global Herceptin (Trastuzumab) Sales Market Share by Application (2017-2028)
Figure 32. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2017-2028)
Figure 33. North America Herceptin (Trastuzumab) Sales Market Share by Type (2017-2028)
Figure 34. North America Herceptin (Trastuzumab) Revenue Market Share by Type (2017-2028)
Figure 35. North America Herceptin (Trastuzumab) Sales Market Share by Application (2017-2028)
Figure 36. North America Herceptin (Trastuzumab) Revenue Market Share by Application (2017-2028)
Figure 37. North America Herceptin (Trastuzumab) Sales Share by Country (2017-2028)
Figure 38. North America Herceptin (Trastuzumab) Revenue Share by Country (2017-2028)
Figure 39. United States Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Herceptin (Trastuzumab) Sales Market Share by Type (2017-2028)
Figure 42. Europe Herceptin (Trastuzumab) Revenue Market Share by Type (2017-2028)
Figure 43. Europe Herceptin (Trastuzumab) Sales Market Share by Application (2017-2028)
Figure 44. Europe Herceptin (Trastuzumab) Revenue Market Share by Application (2017-2028)
Figure 45. Europe Herceptin (Trastuzumab) Sales Share by Country (2017-2028)
Figure 46. Europe Herceptin (Trastuzumab) Revenue Share by Country (2017-2028)
Figure 47. Germany Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 48. France Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Herceptin (Trastuzumab) Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Herceptin (Trastuzumab) Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Herceptin (Trastuzumab) Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Herceptin (Trastuzumab) Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Herceptin (Trastuzumab) Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Herceptin (Trastuzumab) Revenue Share by Region (2017-2028)
Figure 58. China Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 61. India Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Herceptin (Trastuzumab) Sales Market Share by Type (2017-2028)
Figure 68. Latin America Herceptin (Trastuzumab) Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Herceptin (Trastuzumab) Sales Market Share by Application (2017-2028)
Figure 70. Latin America Herceptin (Trastuzumab) Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Herceptin (Trastuzumab) Sales Share by Country (2017-2028)
Figure 72. Latin America Herceptin (Trastuzumab) Revenue Share by Country (2017-2028)
Figure 73. Mexico Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Herceptin (Trastuzumab) Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Herceptin (Trastuzumab) Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Herceptin (Trastuzumab) Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Herceptin (Trastuzumab) Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Herceptin (Trastuzumab) Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Herceptin (Trastuzumab) Revenue Share by Country (2017-2028)
Figure 83. Turkey Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Herceptin (Trastuzumab) Revenue (2017-2028) & (US$ Million)
Figure 86. Herceptin (Trastuzumab) Value Chain
Figure 87. Herceptin (Trastuzumab) Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed